Literature DB >> 2521428

Altered hepatic fatty acid metabolism in endotoxicosis: effect of L-carnitine on survival.

N Takeyama1, D Takagi, N Matsuo, Y Kitazawa, T Tanaka.   

Abstract

The activities of palmitoyl-coenzyme A (CoA) synthetase, carnitine acetyltransferase (CAT), and carnitine palmitoyltransferase (CPT) and the levels of ketone bodies, reduced coenzyme A (CoASH), carnitine, and their esters, which are involved in fatty acid metabolism, in rat liver and plasma were measured after the administration of Escherichia coli lipopolysaccharide (LPS). We also studied the effect of L-carnitine treatment before LPS administration on survival and on hepatic fatty acid metabolism. The activities of CAT and CPT and the concentrations of ketone bodies, CoA, and carnitine derivatives (except for malonyl-CoA) declined in the liver after LPS administration. The activity of palmitoyl-CoA synthetase was changed little after LPS administration, and the level of hepatic malonyl-CoA increased significantly, suggesting that LPS causes activated fatty acids to undergo esterification and lipogenesis rather than oxidation. Treatment of rats with L-carnitine before LPS greatly increased the survival rate, but did not affect enzymes that metabolize fatty acids, CoA, or carnitine derivatives in the liver. Further studies are necessary to elucidate the mechanism of the effect of carnitine on post-LPS survival.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2521428     DOI: 10.1152/ajpendo.1989.256.1.E31

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

1.  FGF21 is increased by inflammatory stimuli and protects leptin-deficient ob/ob mice from the toxicity of sepsis.

Authors:  Kenneth R Feingold; Carl Grunfeld; Josef G Heuer; Akanksha Gupta; Martin Cramer; Tonghai Zhang; Judy K Shigenaga; Sophie M Patzek; Zoe W Chan; Arthur Moser; Holly Bina; Alexei Kharitonenkov
Journal:  Endocrinology       Date:  2012-04-02       Impact factor: 4.736

2.  Preliminary studies on hepatic carnitine palmitoyltransferase in dairy cattle with or without fatty liver.

Authors:  H Mizutani; T Sako; Y Toyoda; T Kawabata; N Urumuhang; H Koyama; S Motoyoshi
Journal:  Vet Res Commun       Date:  1999-12       Impact factor: 2.459

Review 3.  Mitochondrial quality control mechanisms as potential therapeutic targets in sepsis-induced multiple organ failure.

Authors:  You Wu; Yong-Ming Yao; Zhong-Qiu Lu
Journal:  J Mol Med (Berl)       Date:  2019-02-21       Impact factor: 4.599

4.  Rat liver peroxisomal and mitochondrial fatty acid oxidation in sepsis.

Authors:  T Yamamoto
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

5.  Association between 4-year all-cause mortality and carnitine profile in maintenance hemodialysis patients.

Authors:  Yuiko Kamei; Daigo Kamei; Ken Tsuchiya; Michio Mineshima; Kosaku Nitta
Journal:  PLoS One       Date:  2018-08-22       Impact factor: 3.240

6.  Septic Shock Nonsurvivors Have Persistently Elevated Acylcarnitines Following Carnitine Supplementation.

Authors:  Michael A Puskarich; Charles R Evans; Alla Karnovsky; Arun K Das; Alan E Jones; Kathleen A Stringer
Journal:  Shock       Date:  2018-04       Impact factor: 3.454

7.  Effects of L-carnitine on serum triglyceride and cytokine levels in rat models of cachexia and septic shock.

Authors:  B K Winter; G Fiskum; L L Gallo
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

8.  LPS-induced serum TNF production and lethality in mice: effect of L-carnitine and some acyl-derivatives.

Authors:  V Ruggiero; C M D'Urso; C Albertoni; S Campo; P Foresta; E A Martelli
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

9.  Effect of Levocarnitine vs Placebo as an Adjunctive Treatment for Septic Shock: The Rapid Administration of Carnitine in Sepsis (RACE) Randomized Clinical Trial.

Authors:  Alan E Jones; Michael A Puskarich; Nathan I Shapiro; Faheem W Guirgis; Michael Runyon; Jason Y Adams; Robert Sherwin; Ryan Arnold; Brian W Roberts; Michael C Kurz; Henry E Wang; Jeffrey A Kline; D Mark Courtney; Stephen Trzeciak; Sarah A Sterling; Utsav Nandi; Deepti Patki; Kert Viele
Journal:  JAMA Netw Open       Date:  2018-12-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.